Cancer Immune System: A focus on clinical trails of Cancer Vaccines

ISSN: 0973-7510

E-ISSN: 2581-690X

Vemuri Praveen Kumar¹ , Raavi Chakrapani² and Mummalaneni Krishna Prasad³

¹Department of Biotechnology, K L University, Vaddeswaram, Guntur Dist, India.

²Department of Biotechnology, MIC College of Technology, Kanchikacherla, Krishna District, India.

³Department of Biotechnology, Gokaraju Rangaraju Institute of Engineering & Technology, Hyderabad, India.

J Pure Appl Microbiol. 2011;5(1):441-444

Received: 12/06/2010 | Accepted: 28/07/2010 | Published: 30/04/2011

Abstract

Cancer became a big question for scientific community as no existing treatments could solve the problems related to this dreadful disease. Research is in well progress since half century but it failed to give a right solution to fight against it. However the developments in science and technology facilitated scientists to develop new methods of treatment. One such mile stone treatment for cancer that is giving good hope to the people is cancer vaccines. The aim of cancer vaccines is to stimulate the immune system to be able to recognise cancer cells as abnormal and destroy them. Majorly, cancer vaccine research is in progress to develop universal as well as specific cancer vaccines. In the present paper the developments in cancer thearapy especially by empahising vaccine development against cancer was discussed.

Keywords

Cancer Vaccines, Clinical Trials, Immune System, DNA Vaccines

Download PDF

Article Metrics

Article View: 630

JPAM.5.1.71 (203 downloads)

Share This Article

© The Author(s) 2011. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.